Congo vs South Sudan: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Congo
1.6%
in 2024
South Sudan
1.7%
in 2024
Congo rank
19th
South Sudan rank
18th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Congo
- South Sudan
How they compare
South Sudan currently reports 1.7% against 1.6% in Congo, a difference of 0.1%.
That makes South Sudan's figure about 1.1 times Congo's.
Across all 10 years both countries report, South Sudan has been ahead every year.
Congo ranks 19th and South Sudan ranks 18th of 215 countries.
South Sudan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Congo | South Sudan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.6% | 4.2% | 2.6% | South Sudan |
| 2020s | 1.6% | 2.2% | 0.6% | South Sudan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Congo or South Sudan?
- South Sudan, at 1.7% against 1.6% in Congo as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Congo and South Sudan?
- 0.1%, with South Sudan ahead.
- How many years of comparable data are there for Congo and South Sudan?
- 10 years are reported by both, from 2015 to 2024.
- How do Congo and South Sudan rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Congo ranks 19th and South Sudan ranks 18th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.